Camber (Camber)
Zafirlukast Tablet, Film Coated
Product Images NDC 72162-2361
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zafirlukast (NDC 72162-2361). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label (Lbl721622361)
Label for Zafirlukast Tablets, 20 mg film-coated tablets, oral use, containing 60 tablets per container. The label includes storage instructions, a barcode, and mentions the product is relabeled by Bryant Ranch Prepack and manufactured by Annora Pharma Pvt. Ltd. The NDC 72162-2361 is prominently displayed.*
Zafirlukastfig (Zafirlukastfig)
A line graph depicting mean beta-2 agonist use (puffs per day) over a 14-week trial period, comparing placebo, Zafirlukast 20 mg twice a day, and Cromolyn sodium 1600 mcg four times a day. The y-axis shows adjusted treatment means of puffs per day, and the x-axis shows trial weeks.*
Zafirlukaststructure (Zafirlukaststructure)
Chemical structure diagram of Zafirlukast, showing its molecular arrangement as typically depicted in pharmaceutical labeling and scientific references.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
